Autorisation d’accès précoce refusée à la spécialité ZURZUVAE (zuranolone) dans l'indication « traitement de la dépression sévère du post-partum (DPP) suivant l’accouchement chez les adultes. »
See also
HAS opinions and decisions
23/06/2025
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
10aRj3PcKjeTaauw
